Bioactive Transmembrane Proteins

About NewEast Biosciences

NewEast Biosciences is a specialized life sciences reagent company with a decade-long focus on creating high-specificity research tools for studying cellular signaling and cancer biology. Its core technological differentiation lies in antibodies that selectively detect the active, GTP-bound state of GTPases and mutated forms of oncogenes, filling a niche in basic and translational research. The company has expanded its portfolio to include bioactive membrane proteins, biosimilar antibodies, and assay kits, serving academic, pharmaceutical, and biotech researchers globally. Its products are validated by over 1,000 peer-reviewed publications, indicating strong adoption within the scientific community.

Therapeutic Areas